Unione Europea - lettone - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - rekombinanto vezikulārā stomatīta vīruss (celms, indiana), ar dzēšanas aploksnes glikoproteīnu, aizstāj ar zaira ebolavirus (celms kikwit 1995) virsmas glikoproteīnu - hemorāģisko drudzi, ebola - vakcīnas - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. izmantot ervebo būtu saskaņā ar oficiālās rekomendācijas.

Grecia - greco - Εθνικός Οργανισμός Φαρμάκων

seqirus netherlands b.v., amsterdam-1105bj, the netherlands paasheuvelweg 28, 1105bj amsterdam - a/brisbane/02/2018 (h1n1) pdm09 - like strain (a/idaho/07/2018); a/kansas/14/2017 (h3n2) - like strain (a/indiana/08/2018); b/colorado/06/2017 - like strain (b/iowa/06/2017); b/phuket/3073/2013 - like strain (b/singapore/inftt-16-0610/2016) - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - (15+15+15+15)mcg/0,5ml pf.syr (1 δόση) - a/brisbane/02/2018 (h1n1) pdm09 - like strain (a/idaho/07/2018) 15mcg; a/kansas/14/2017 (h3n2) - like strain (a/indiana/08/2018) 15mcg; b/colorado/06/2017 - like strain (b/iowa/06/2017) 15mcg; b/phuket/3073/2013 - like strain (b/singapore/inftt-16-0610/2016) 15mcg - influenza, purified antigen

Unione Europea - croato - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - рекомбинантный virus везикулярного стоматита (soj indiana) s brisanje koverti glikoprotein, zamijenjen zair ebole (soj киквите 1995) površinski glikoprotein - Геморрагическая groznice ebole - cjepiva - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. korištenje ervebo moraju biti u skladu sa službenim preporukama.

Unione Europea - islandese - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - skal læknir hafa blöðrum bólgur veira (álag indiana) með eyðingu umslagið glýkóprótein, komi með zaire ebolavirus (álag kikwit 1995) yfirborðið glýkóprótein - blæðandi hiti, ebóla - bóluefni - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. notkun ervebo ætti að vera í samræmi við opinbera tillögur.

Unione Europea - tedesco - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - rekombinante vesikuläre stomatitis-virus (stamm indiana) mit einem löschen des envelope-glykoprotein, ersetzt, mit dem zaire ebolavirus (stamm kikwit 1995) oberfläche glykoprotein - hämorrhagische fieber, ebola - - impfstoffe - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. die verwendung von ervebo sollte in übereinstimmung mit den offiziellen empfehlungen.

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

vifor (international) inc. - haemagglutininum influenzae a (h3n2) (virus stamm a/kansas/14/2017 (h3n2)-like: derived from a/indiana/08/2018), haemagglutininum influenzae a (h1n1) (virus stamm a/brisbane/02/2018 (h1n1)-like: derived from a/idaho/07/2018), haemagglutininum influenzae b (virus stamm b/colorado/06/2017-like: reassortant from b/iowa/06/2017 (victoria lineage)) - suspension injectable - haemagglutininum influenzae a (h3n2) (virus stamm a/kansas/14/2017 (h3n2)-like: derived from a/indiana/08/2018) 15 µg, haemagglutininum influenzae a (h1n1) (virus stamm a/brisbane/02/2018 (h1n1)-like: derived from a/idaho/07/2018) 15 µg, haemagglutininum influenzae b (virus stamm b/colorado/06/2017-like: reassortant from b/iowa/06/2017 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus stamm b/phuket/3073/2013-like: reassortant from b/singapore/inftt-16-0610/2016 (yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, magnesii chloridum hexahydricum, natrii dihydrogenophosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.7 mg, kalium 0.1 mg, residui: polysorbatum 80, cetrimidum, propiolactonum. - aktive immunisierung gegen influenza , ab 9 jahren - les vaccins

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

vifor (international) inc. - haemagglutininum influenzae a (h3n2) (virus stamm a/kansas/14/2017 (h3n2)-like: derived from a/indiana/08/2018), haemagglutininum influenzae a (h1n1) (virus stamm a/brisbane/02/2018 (h1n1)-like: derived from a/idaho/07/2018), haemagglutininum influenzae b (virus stamm b/colorado/06/2017-like: reassortant from b/iowa/06/2017 (victoria lineage)) - sospensione iniettabile - haemagglutininum influenzae a (h3n2) (virus stamm a/kansas/14/2017 (h3n2)-like: derived from a/indiana/08/2018) 15 µg, haemagglutininum influenzae a (h1n1) (virus stamm a/brisbane/02/2018 (h1n1)-like: derived from a/idaho/07/2018) 15 µg, haemagglutininum influenzae b (virus stamm b/colorado/06/2017-like: reassortant from b/iowa/06/2017 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus stamm b/phuket/3073/2013-like: reassortant from b/singapore/inftt-16-0610/2016 (yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, magnesii chloridum hexahydricum, natrii dihydrogenophosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.7 mg, kalium 0.1 mg, residui: polysorbatum 80, cetrimidum, propiolactonum. - aktive immunisierung gegen influenza , ab 9 jahren - vaccini

Unione Europea - spagnolo - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - recombinante del virus de la estomatitis vesicular (cepa indiana) con una supresión de la glicoproteína de la envoltura, se sustituirá por el de zaire ébola (cepa de kikwit 1995) glicoproteína de superficie - la fiebre hemorrágica, el Ébola - vacunas - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. el uso de ervebo debe estar en conformidad con las recomendaciones oficiales.

Unione Europea - francese - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - recombinant virus de la stomatite vésiculaire (souche indiana) avec une suppression de la glycoprotéine d'enveloppe, remplacé par le zaïre ebola (souche de kikwit en 1995) glycoprotéine de surface - fièvre hémorragique À virus ebola - vaccins - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. l'utilisation de ervebo doit être en conformité avec les recommandations officielles.

Unione Europea - italiano - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - ricombinante del virus della stomatite vescicolare (ceppo indiana) con l'eliminazione della glicoproteina busta, sostituito con lo zaire ebolavirus (ceppo kikwit 1995) glicoproteina di superficie - febbre emorragica di ebola - vaccini - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. l'uso di ervebo dovrebbe essere in conformità con le raccomandazioni ufficiali.